Description
​Opioid use has affected all groups of individuals across the United States, including pregnant and parenting individuals. Infants exposed to opioids prenatally can experience symptoms of withdrawal after birth, a condition known as neonatal opioid withdrawal syndrome (NOWS). While NOWS is not a lifelong condition and infants with prenatal exposure to opioids can make a full recovery in the first few months of life, they may also face developmental alterations. Prenatal opioid exposure can be associated with exposure to other substances in utero as well, including alcohol, which is a leading contributor to developmental delays.
This course presents 2 tracks focused on:
1- Hospital-based pediatricians (discharging the infant from the hospital)
2- Community-based pediatricians and subspecialists (receiving the infant into a medical home)
​Learning objectives - Hospital Track
- Understand the steps for developing, updating, and documenting a plan of safe/supportive care for the infant and the birth parent(s).
- Identify and address family concerns related to caring for infants exposed to opioids prenatally, including providing appropriate anticipatory guidance to families on caring for their infants.
- Provide information to the family regarding community and pediatric subspecialty services and Early Intervention (EI) or neonatal developmental follow-up services, as appropriate, and address family needs with a referral.
- Assess families for social drivers of health and behavioral, social, and emotional health, and create appropriate plans to address any needs that are identified.
- Assess and address all family, birth parent, and primary caregiver needs, including needs for ongoing OUD treatment, medication treatment for OUD (MOUD), and supportive recovery services.
- Review the birth parent’s medical record for infectious disease and OUD-related common comorbidities to inform appropriate adult and pediatric follow-up care.
​Learning objectives - Community track
- Understand the course for developing, updating, and documenting in the patient chart of a plan of safe/supportive care for the infant and the birth parent.
- Identify and address family concerns related to caring for infants exposed to opioids prenatally, including providing appropriate anticipatory guidance to families on caring for their infants.
- Assess families for social drivers of health and behavioral, social, and emotional health, and create appropriate plans to address identified needs.
- Provide appropriate developmental surveillance, screening, and follow-up care for patients with prenatal exposure.
- Assess and address the needs for pediatric subspecialty care, including screening and follow-up care for vision and hearing concerns.
- Assess and address birth parents and primary caregivers needs for ongoing OUD treatment, such as, medication treatment for OUD (MOUD), addiction treatment, supportive recovery services, and mental and emotional health care needs.
Course Details
- Start Date: April 30, 2024
- Online Access Expires: April 29, 2027
- Credit Expires: April 29, 2027
- Course ID: 60526
Acknowledgements
​This project is supported by the Centers for Disease Control and Prevention (CDC) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $500,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, CDC/HHS, or the U.S. Government.
Faculty
​Subject matter experts/Faculty
- Hannah Fischer, MD, FAAP
- Catherine Lipman, MD, FAAP
- Tanner Wright, MD, FAAP
Online Reviewers
- Wanda D. Barfield, MD, MPH, FAAP, RADM, USPHS (ret.)
- Munish Gupta, MD, MMSc, FAAP
- Andrew Terranella, MD, FAAP, CAPT
AAP Staff
- Rachel Daskalov, MHA
- Tamiko O'Brill, MBA, MS
- Kristen Minaglia, MPH
- Clara Petrisor, MA
Instructional Design Consultants
- Diane Guerriero
- Teri Blommaert
- Robbie Proulx
